News

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...
U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...
Michael Yee, Jefferies senior biotech analyst, joins CNBC's 'Squawk on the Street' to discuss how AI could fuel drug ...
FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...
ATLANTA and BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- ABLi Therapeutics ("ABLi”), a biotechnology company developing ...
Checkpoint Therapeutics Inc.'s planned $355 million sale to Sun Pharmaceuticals Inc. will likely siphon value from public ...
The North Carolina Biotechnology Center’s newly relaunched Career Center site is now fully automated. On one recent day, the site listed nearly 2,000 jobs – about 15 times more jobs than the previous ...
Triple Hair Group Inc. ("Triple Hair” or the "Company”), a company specializing in the development of innovative treatments for androgenic alopecia, is pleased to announce the appointment of Paul ...
US FDA places clinical hold on Rocket Pharma's gene therapy phase 2 trial of RP-A501 to treat Danon disease: Cranbury, New Jersey Wednesday, May 28, 2025, 14:00 Hrs [IST] Rocket P ...
Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...
Russia proposes second round of direct talks with Ukraine in Istanbul Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and ...
Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars to ...